RELAPSE
Clinical trials for RELAPSE explained in plain language.
Never miss a new study
Get alerted when new RELAPSE trials appear
Sign up with your email to follow new studies for RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells battle Tough-to-Treat blood cancer
Disease control CompletedThis early-phase trial tested a new treatment called CAR-T cell therapy for patients whose B-cell lymphoma had returned or stopped responding to standard treatments. Doctors collected and genetically modified the patients' own immune cells to better target and fight the cancer ce…
Matched conditions: RELAPSE
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New pill tested for tough blood cancers after other treatments fail
Disease control CompletedThis early-stage study tested a new oral drug called LP-108, given alone or with another cancer drug (azacitidine), in adults with advanced blood cancers that had returned or did not respond to prior treatments. The main goals were to find a safe dose, see how the body processes …
Matched conditions: RELAPSE
Phase: PHASE1 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC